← Leaderboards
Karim I Budhwani
Cerflux, Inc.
$301,148
Attributed
$301,148
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249.1K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$301,148 · 1
By mechanism
R43$301,148 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Infusion Procedures”
- James Dale Berry · Brigham And Women'S Hospital$17,050,216
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Wilton B Williams · Duke University$10,993,477
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Bronwen Shaw · Medical College Of Wisconsin$10,328,749
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
Infusion ProceduresOperative Surgical ProceduresExcisionIneffective TherapiesMachine LearningMalignant NeoplasmsEffective TherapyEfficacy TestingBiomimeticsIndividual PatientLegal PatentChemotherapy-Oncologic ProcedureClinical Decision-MakingMalignant Neoplasm Of PancreasCollaborationsCancer TherapyComprehensive Cancer CenterBaseCostCell LineCessation Of LifeDiagnosisIn VitroOvertreatment
Grant awards (2)
Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.$52,000
R43 · FY2021 · CA · contact PI
Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.$249,148
R43 · FY2020 · CA · contact PI